V2 Trial: A phase I study of venetoclax and CPX-351 for young patients with relapsed/refractory acute leukemia von Agresta, Laura, O'Brien, Maureen Megan, O'Brien, Eric Justin, Norris, Robin Elizabeth, Breese, Erin Haag, Burns, Karen Cristly, Mizukawa, Benjamin, Ryan, Thomas D, Desai, Pankaj B, Vinks, A.a., Grimes, H. Leighton, Absalon, Michael, Perentesis, John Peter

Volltext

Kidney Injury Molecule-1 and its association with delayed clearance and drug exposure in pediatric oncology patients treated with high dose methotrexate von Bukowinski, Andrew J., Mizuno, Tomoyuki, Fukuda, Tsuyoshi, Vinks, A.a., Goldstein, Stuart, Lane, Adam, Perentesis, John Peter, O'Brien, Maureen Megan

Volltext

Pharmacogenetic variants associated with differential sirolimus clearance in pediatric patients von Wright, Jordan, Karns, Rebekah, Mizuno, Tomoyuki, Basu, Mitali, Weiss, Brian D., Adams, Denise, Vinks, A.a., Aronow, Bruce, Perentesis, John Peter

Volltext

Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS von Čabovska, B., Cox, S.L., Vinks, A.A.

Volltext

A phase I trial of IMC A12 and temsirolimus in children with refractory solid tumors: A Children’s Oncology Group study von Fouladi, Maryam, Perentesis, John Peter, Wagner, Lars M., Ingle, Ashish M, Thomas, George, Krueger, Darcy A., Houghton, Peter, Vinks, A.A., Doyle, L. Austin, Weigel, Brenda, Blaney, Susan

Volltext

Novel therapeutic modalities: the future is now von Choi, Y., Vinks, A.A., Graaf, P.H. van der

Volltext bestellen

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2: Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patien... von Le Brun, P.P.H, de Boer, A.H, Mannes, G.P.M, de Fraı̂ture, D.M.I, Brimicombe, R.W, Touw, D.J, Vinks, A.A, Frijlink, H.W, Heijerman, H.G.M

Volltext

Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology von Bergan, S., Brunet, M., Hesselink, D.A., Johnson-Davis, K.L., Kunicki, P.K., Lemaitre, F., Marquet, P., Molinaro, M., Noceti, O., Pattanaik, S., Pawinski, T., Seger, C., Shipkova, M., Swen, J.J., Gelder, T. van, Venkataramanan, R., Wieland, E., Woillard, J.B., Zwart, T.C., Barten, M.J., Budde, K., Dieterlen, M.T., Elens, L., Haufroid, V., Masuda, S., Millan, O., Mizuno, T., Moes, D.J.A.R., Oellerich, M., Picard, N., Salzmann, L., Tonshoff, B., Schaik, R.H.N. van, Vethe, N.T., Vinks, A.A., Wallemacq, P., Asberg, A., Langman, L.J.

Volltext bestellen

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2 von Le Brun, P.P.H, de Boer, A.H, Mannes, G.P.M, de Fraı̂ture, D.M.I, Brimicombe, R.W, Touw, D.J, Vinks, A.A, Frijlink, H.W, Heijerman, H.G.M

Volltext

Pharmacokinetics of high-dose weekly Ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patients von Mehta, P.A., Vinks, A.A., Filipovich, A.H., Vaughn, G.A., Fearing, D.N., Sper, C., Davies, S.M.

Volltext

Pharmacokinetics of Aztreonam in Healthy Subjects and Patients with Cystic Fibrosis and Evaluation of Dose-Exposure Relationships Using Monte Carlo Simulation von VINKS, Alexander A, VAN ROSSEM, Ronald N, MATHOT, Ron A. A, HEIJERMAN, Harry G. M, MOUTON, Johan W

Volltext

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome : A cost-effectiveness analysis von VAN LENT-EVERS, N. A. E. M, MATHOT, R. A. A, GEUS, W. P, VAN HOUT, B. A, VINKS, A. A. T. M. M

Volltext